Posted in Web Novavax Plans FDA Filing for COVID-19 Vaccine after … July 28, 2021 Novavax plans to file for FDA approvals in the third quarter for its COVID-19 vaccine NVX-CoV2373, after it showed 90.4% overall efficacy, and 93% efficacy against the five most prevalent SARS-CoV … https://www.genengnews.com/news/novavax-plans-fda-filing-for-covid-19-vaccine-after-positive-efficacy-data/